发布: 2014年08月05日第4卷第15期 DOI: 10.21769/BioProtoc.1195 浏览次数: 10285
评审: Kanika GeraAnonymous reviewer(s)
Abstract
Hepatitis E virus (HEV) is one of the main causes of acute hepatitis worldwide. Infections are particularly severe in pregnant women and chronic hepatitis E is known to occur in immunocompromised patients. Current therapy (ribavirin or pegylated alpha interferon) has severe side effects and cannot be employed in all patients. In order to evaluate potential new inhibitors of HEV replication, a virus yield assay can be employed in which the amount of viral RNA progeny released into the culture medium is quantified by reverse-transcription quantitative PCR (RT-qPCR) (Debing et al., 2014).
Materials and Reagents
Equipment
Procedure
文章信息
版权信息
© 2014 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Debing, Y., Dallmeier, K. and Neyts, J. (2014). Infectious Virus Yield Assay for Hepatitis E Virus. Bio-protocol 4(15): e1195. DOI: 10.21769/BioProtoc.1195.
分类
微生物学 > 微生物-宿主相互作用 > 病毒
微生物学 > 微生物遗传学 > RNA
分子生物学 > RNA > RNA 检测
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link